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Objective: Human exposure to benzene is associated with multiple adverse health effects with an increased risk of
developing carcinogenesis. Benzene exposure is known to affect many critical organs including the hematological,
hepatic, renal, lung, and cardiac functions. The purpose of this study is to examine the health effects of benzene
exposure among nonsmoking subjects from a prolonged flaring incident that occurred at the British petroleum (BP)
refinery in the Texas City, Texas.
Methods: The study included nonsmoking subjects who had been exposed and unexposed to benzene. Using
medical charts, clinical data including white blood cell (WBC) counts, platelet counts, hemoglobin, hematocrit,
blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), and alanine
amino transferase (ALT) in nonsmoking subjects exposed to benzene were reviewed and analyzed and compared
with unexposed adults.
Results: A total of 1422 nonsmoking subjects (benzene exposed, n = 1093 and unexposed, n = 329) were included.
Benzene exposed subjects had significantly higher levels of WBC (× 103 per μL) counts (7.7 ± 2.2 versus 6.8 ± 1.7,
P = 0.001) and platelet (× 103 per μL) counts (288.8 ± 59.0 versus 245.3 ± 54.4, P = 0.001) compared with the
unexposed subjects. The mean serum creatinine (mg/dL) levels were also significantly increased in the benzene
exposed group compared with the unexposed group (1.1 ± 0.4 versus 0.8 ± 0.2, P = 0.001). Serum levels of ALP (IU/L)
was significantly elevated in the benzene exposed subjects compared with the unexposed subjects (87.3 ± 22.6
versus 69.6 ± 16.5, P = 0.001). Similarly, benzene exposed subjects had significantly higher levels of AST and ALT
compared with those unexposed subjects.
Conclusion: Benzene exposure from the prolonged BP flaring incident caused significant alterations in hematological
and liver markers indicating that these nonsmoking residents exposed to refinery chemicals may be at a higher risk of
developing hepatic or blood related disorders.
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Benzene is a major constituent of petroleum and occurs
naturally in crude oil. It is also formed as a result of the
incomplete combustion of fossil fuels such as petroleum
products and coal. In addition, benzene is a commer-
cially important intermediate in the manufacture of
many chemicals [1-4]. Thus, petroleum refining indus-
tries are the major sources of benzene and other toxic
chemicals. Benzene is one of the most widely used che-
micals in the synthesis of various polymers, resins, and
synthetic fibers. Moreover, benzene is a common com-
ponent of gasoline [5]. As a volatile organic compound,
benzene is one of the main contributors to air pollutants
in the environment. It is found in the environment as
a contaminant from both human activities and natural
processes. Furthermore, benzene is an intrinsic compo-
nent of tobacco smoke, and tobacco smokers have a
higher body burden of benzene than nonsmokers [6].
Human exposure to benzene has significant deleterious
health effects. Exposure to benzene is associated with the
risk of blood disorders, including leukemia, lymphoma,
aplastic anemia, pancytopenia and chromosomal aberra-
tions [3,7-10]. In addition, exposure to benzene can cause
a wide range of adverse effects on the central nervous
system, hematological, hepatic, renal, and lung functions
[11-15]. Thus, communities surrounding petroleum re-
fineries have significant health risks due to the increased
probability of being exposed to benzene and other toxic
chemicals.
Benzene enters the body primarily through inhalation
of contaminated air or through direct contact with the
skin. It is readily absorbed into the body when inhaled
into the lungs and excreted as metabolites such as phe-
nol, benzene oxide, benzoquinone, muconaldehydes,
hydroquinone, and catechol in the urine [16]. The toxic
effects of benzene are thought to arise from its meta-
bolites, particularly from benzoquinone and the muco-
naldehydes. Evidence suggests that benzene-induced
toxicity involves multiple mechanisms such as oxidative
stress, DNA damage, disruption of the cell cycle, and
programmed cell death [17-19]. In addition, immune
dysfunction has been hypothesized to contribute to
benzene toxicity as benzene can interfere with innate,
humoral and cellular immunity [20,21].
In 2010, a flaring incident at the British petroleum
(BP) refinery facility led to the release of a huge amount
of toxic chemicals into the air in Texas City, Texas [22,23].
As a consequence, over 500,000 pounds of toxic chemicals,
including over 17,000 pounds of benzene was released into
the skies threatening the health of the residents of Texas
City and the surrounding communities [22-24]. The
Galveston County District Clerk’s Office estimates that
over 50,000 people are presumed to be affected by the
incident.To understand the potential health effects of ambient
benzene exposure resulting from the BP flaring inci-
dent, a series of studies were conducted examining the
hematological and hepatic functions in affected sub-
jects. The pilot study findings indicated that benzene
exposure resulting from the BP flaring incident signifi-
cantly altered the hematological and hepatic indices in
the exposed subjects compared with the unexposed
subjects [25]. Assessment of health consequences of
benzene exposure in pediatric subjects also indicated
similar alterations in hematological and hepatic func-
tions following the same prolonged BP flaring incident
in Texas City, Texas [26].
The routine assessment of patients’ hematological
profile involving the measurement of their white blood cell
(WBC) counts, platelet counts, hemoglobin, hematocrit,
blood urea nitrogen (BUN), creatinine and other indices is
used to monitor and evaluate the status of a patients’
health including the detection of any changes as a conse-
quence of toxicant exposure, infection, or diseases such as
cancer. Similarly, measurement of serum levels of alkaline
phosphatase (ALP), aspartate amino transferase (AST),
and alanine amino transferase (ALT) are used as markers
for hepatic function [27]. Since benzene exposure is linked
to the development of multiple hematological malignan-
cies [3,7-10], we assessed its health effects by examining
hematological and hepatic profiles in benzene exposed
nonsmoking subjects and compared them with those
unexposed nonsmoking subjects.
Since tobacco smokers may have a higher body bur-
den of benzene than nonsmokers, we tried to eliminate
this variable by examining the health effects of benzene
exposure only among the nonsmoking subjects who
were exposed to the prolonged flaring incident that
occurred at the BP refinery facility.
Subjects and methods
Subjects
This retrospective study was approved by the Quorum
Institutional Review Board. The details of the subjects’
selection and the procedures employed for the clinical
and laboratory evaluations were reported previously
[25,26]. Briefly, residential areas affected by the BP
refinery emission due to the flaring event were initially
identified and the subjects exposed to the emission
were selected from the affected areas of surrounding
communities of Texas City, Texas (Figure 1). Specifically,
these subjects experienced a prolonged and involuntary
exposure to benzene for up to 40 days following the BP
refinery flaring incident that occurred on April 6, 2010
and lasted through May 16, 2010. Subjects who were
unexposed to benzene were drawn from primary care
clinics located approximately 30–50 miles away from
the BP refinery plant [25,26]. Unexposed subjects had
A B
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Figure 1 Map showing the location of the incident of British petroleum (BP) refinery that spewed hundreds of thousands of pounds of
toxic chemicals including benzene and carbon monoxide into the skies of Texas City, Texas for 40 days from April 6 to May 16, 2010.
During the incident, the wind originated from south to north and dispersed the discharged benzene impacting the people residing in the northern
parts of the Texas City. A. Location of Texas City, Texas. B. Depicted intensity of benzene exposure from BP incident surrounding neighborhoods of
Texas City, Texas. The red, orange, and yellow colors depict the higher (red) to reduced (orange) to low (yellow) intensity of benzene exposure.
C. Scattered dots represent the location/address of the study participants who were exposed to benzene following a flaring incident at the BP
refinery and surrounding areas. D. A closer look at the affected area by the benzene exposure and the location of study participants (scattered dots).
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selected randomly by the primary care physician. Subjects
(exposed and unexposed to benzene) with smoking history
were excluded from the study. Demographic and clinical
laboratory data were collected and included in this ana-
lysis. The study was conducted according to the ethical
principles of the Declaration of Helsinki. To comply with
the Health Insurance Portability and Accountability Act
(HIPAA), confidentiality of information was secured by
utilizing text encryption, password protection and limited
personnel involvement.
Data analysis
Medical charts of the benzene exposed and unexposed
subjects were reviewed and the clinical data was proc-
essed for statistical analysis. Clinical data such as WBC
counts, platelet counts, hemoglobin, hematocrit, BUN,
creatinine, ALP, AST, and ALT levels were assessed and
compared between the benzene exposed and unexposed
subjects.
Statistics
Data from all laboratory examinations in this study was
systematically collected from the subjects’ medical charts
and subjected to statistical analysis. Descriptive statisticswere used to assess patient demographics which included
means and standard deviations for each group. Variables
included were WBC, platelets, hemoglobin, hematocrit,
creatinine, BUN, ALP, AST, and ALT. Student’s t-test
was used to assess the differences between the benzene
exposed and unexposed groups. The significance level
was predetermined at an alpha level of 0.05.
Results
A total of 1422 subjects were included in this study. Of
the 1422 subjects, 329 were unexposed and 1093 were
exposed to benzene. The subjects’ demographics are
shown in Table 1. The mean age of the subjects was
47 years in each group. Among the unexposed subjects
(n = 329), there were 131 (40%) male and 198 (60%)
female subjects. In the benzene exposed group (n = 1093),
there were 610 (56%) male and 483 (44%) female subjects.
The median time from the time of disaster to the time
of the laboratory testing for the exposed group was 145
(range, 77–439) days.
The results presented in Table 2 show the differences in
hematological and hepatic markers between the unexposed
and exposed subjects to benzene. Subjects who were ex-
posed to benzene experienced significantly increased mean
WBC counts (× 103 per μL) compared with the unexposed
Table 1 Demographics of the study subjects
Demographics Unexposed Benzene exposed
Total subjects (N) 329 (100%) 1093 (100%)
Mean age 47 years 47 years
Gender
Male 131 (40%) 610 (56%)
Female 198 (60%) 483 (44%)
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the mean platelet counts (× 103 per μL) in the benzene
exposed group was significantly elevated compared
with the unexposed group (288.8 ± 59.0 versus 245.3 ±
54.4, P = 0.001). The mean hemoglobin (g/dL) levels
increased significantly in the benzene exposed group
compared with the unexposed group (14.9 ± 1.3 versus
14.0 ± 1.2, P = 0.001). The percentage of hematocrit
increased significantly among the benzene exposed
subjects compared with the unexposed subjects (43.0 ± 3.0
versus 41.9 ± 3.4, P = 0.001). The mean serum creatinine
(mg/dL) levels were significantly increased in the benzene
exposed group compared with the unexposed group
(1.1 ± 0.4 versus 0.8 ± 0.2, P = 0.001). BUN (mg/dL) levels
were significantly increased in benzene exposed subjects
compared with the unexposed subjects (15.6 ± 4.6 versus
13.5 ± 3.6, P = 0.001). Compared with the unexposed
subjects, benzene exposed subjects had significantly ele-
vated levels of ALP (87.3 ± 22.6 versus 69.6 ± 16.5 IU/L,
P = 0.001). The mean AST (IU/L) levels were signifi-
cantly higher in the benzene exposed group compared
with the unexposed group (27.8 ± 6.8 versus 19.1 ± 4.7,
P = 0.001). The mean serum ALT (IU/L) levels was
increased significantly in the benzene exposed group
compared with the unexposed group (33.9 ± 10.1 versus
20.3 ± 8.6, P = 0.001).Table 2 Comparison of hematological and hepatic indices
between unexposed and exposed nonsmoking subjects
to benzene
Variable
Unexposed Benzene exposed P
Value(N = 329) (N = 1093)
WBC (× 103 per μL) 6.8 ± 1.7 7.7 ± 2.2 0.001*
Platelets (× 103 per μL) 245.3 ± 54.4 288.8 ± 59.0 0.001*
Hemoglobin (g per dL) 14.0 ± 1.2 14.9 ± 1.3 0.001*
Hematocrit (%) 41.9 ± 3.4 43.0 ± 3.0 0.001*
BUN (mg per dL) 13.5 ± 3.6 15.6 ± 4.6 0.001*
Creatinine (mg per dL) 0.8 ± 0.2 1.1 ± 0.4 0.001*
ALP (IU per L) 69.6 ± 16.5 87.3 ± 22.6 0.001*
AST (IU per L) 19.1 ± 4.7 27.8 ± 6.8 0.001*
ALT (IU per L) 20.3 ± 8.6 33.9 ± 10.1 0.001*
*Differences between benzene exposed and unexposed groups are significant.
WBC White blood cells, BUN Blood urea nitrogen, ALP Alkaline phosphatase,
AST Aspartate amino transferase, ALT Alanine amino transferase.The findings presented in Table 3 represent the differ-
ences in hematological and hepatic markers between the
exposed and unexposed subjects to benzene according
to the gender. The mean WBC counts (× 103 per μL)
were significantly higher in male (7.5 ± 2.5 versus 6.7 ±
1.7, P = 0.001) and female (8.0 ± 1.6 versus 6.8 ± 1.6,
P = 0.001) subjects exposed to benzene compared with
the unexposed group. Similarly, the mean platelet counts
(× 103 per μL) in male (267.0 ± 47.7 versus 233.1 ± 48.7,
P = 0.001) and female (316.6 ± 63.5 versus 256.3 ± 53.8,
P = 0.001) subjects exposed to benzene was significantly
elevated compared with the unexposed group. BUN
(mg/dL) was also significantly higher in male (16.1 ± 4.9
versus 14.6 ± 3.2, P = 0.001) and female (14.8 ± 4.5
versus 12.8 ± 3.7, P = 0.001) subjects in the benzene
exposed group compared with the unexposed group.
Similarly, serum creatinine (mg/dL) levels were also
significantly higher in male (1.1 ± 0.3 versus 0.9 ± 0.1,
P = 0.001) and female (0.9 ± 0.2 versus 0.7 ± 0.1, P = 0.001)
subjects in the benzene exposed group compared with the
unexposed group. Conversely, hemoglobin and hematocrit
levels did not differ significantly in male or female subjects
between the benzene exposed and unexposed groups.
The mean serum ALP (IU/L) levels were significantly
elevated in male (84.9 ± 18.3 versus 73.7 ± 16.7, P = 0.001)
and female (90.3 ± 21.9 versus 69.0 ± 18.1, P = 0.001)
subjects in the benzene exposed group compared with
the unexposed group. Similarly, the mean serum AST
(IU/L) levels l were significantly higher in male (29.9 ±
8.5 versus 21.8 ± 5.7, P = 0.001) and female (24.3 ± 6.9
versus 18.0 ± 4.4, P = 0.001) subjects in the benzene
exposed group compared with the unexposed group. The
mean serum levels of ALT (IU/L) was also increased in
male (40.1 ± 13.7 versus 24.3 ± 4.9, P = 0.001) and female
(25.3 ± 5.6 versus 17.4 ± 6.8, P = 0.001) subjects in the
benzene exposed group compared with the unexposed
group (Table 3).
To determine if the subjects’ age had any impact on
the health effects of benzene exposure, the subjects were
categorized into <40 years and, ≥ 40 years age groups
and the clinical findings were compared between the
unexposed and benzene exposed groups. The results in
Table 4 show the differences in hematological and
hepatic markers between the exposed and unexposed
subjects among the two age groups. Although the mean
WBC counts decreased with increasing age in both
groups, the mean WBC counts were significantly higher
in the benzene exposed age-groups compared with their
matched unexposed age-groups. A decreased trend in
the mean platelet counts was seen with the increasing age
in both groups; significantly higher mean platelet counts
were observed in the benzene exposed age-groups
compared with their matched unexposed age-groups.
Conversely, no significant differences were found in
Table 3 Comparison of hematological and hepatic indices between unexposed and benzene exposed nonsmoking
subjects according to gender
Variable Gender Unexposedδ Benzene exposedβ P Value
WBC (× 103 per μL) Male 6.7 ± 1.7 7.5 ± 2.5 0.001*
Female 6.8 ± 1.6 8.0 ± 1.6 0.001*
Platelets (× 103 per μL) Male 233.1 ± 48.7 267.0 ± 47.7 0.001*
Female 256.3 ± 53.8 316.6 ± 63.5 0.001*
Hemoglobin (g per dL) Male 15.1 ± 0.9 15.2 ± 0.8 0.13ψ
Female 13.2 ± 0.8 13.5 ± 2.8 0.25ψ
Hematocrit (%) Male 44.9 ± 2.6 44.9 ± 2.2 0.50ψ
Female 39.9 ± 2.3 40.1 ± 2.3 0.10ψ
BUN (mg per dL) Male 14.6 ± 3.2 16.1 ± 4.9 0.001*
Female 12.8 ± 3.7 14.8 ± 4.5 0.001*
Creatinine (mg per dL) Male 0.9 ± 0.1 1.1 ± 0.3 0.001*
Female 0.7 ± 0.1 0.9 ± 0.2 0.001*
ALP (IU per L) Male 73.7 ± 16.7 84.9 ± 18.3 0.001*
Female 69.0 ± 18.1 90.3 ± 21.9 0.001*
AST (IU per L) Male 21.8 ± 5.7 29.9 ± 8.5 0.001*
Female 18.0 ± 4.4 24.3 ± 6.9 0.001*
ALT (IU per L) Male 24.3 ± 4.9 40.1 ± 13.7 0.001*
Female 17.4 ± 6.8 25.3 ± 5.6 0.001*
*Differences between benzene exposed and unexposed groups are significant.
ψ = did not reach statistical significance.
WBC White blood cells, BUN Blood urea nitrogen, ALP Alkaline phosphatase, AST Aspartate amino transferase, ALT Alanine amino transferase.
δMale unexposed: n = 131; δFemale unexposed: n = 198.
βMale exposed: n = 610; βFemale exposed: n = 483.
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between the unexposed and benzene exposed subjects
irrespective of the age-group. Serum creatinine levels
were increased significantly in the benzene exposed
subjects compared with those in unexposed subjects, in
both age-groups. Similarly, the serum levels of hepatic
enzymes (ALP, AST and ALT) were increased significantly
in the benzene exposed subjects compared with those of
the unexposed subjects, irrespective of age (Table 4).
Discussion
Human exposure to benzene is associated with multiple
toxicities affecting the hematological, hepatic, immuno-
logic, and chromosomal functions and an increased risk
of carcinogenesis. However, the precise mechanism of
benzene induced toxic effects is not fully understood.
Thus, a thorough understanding of the health conse-
quences of benzene exposure is important for developing
approaches to assess the risk in those affected communi-
ties. Since tobacco smokers have a higher body burden
of benzene than nonsmokers [6], the health conse-
quences of benzene exposure from the BP’s flaring incident
may differ among smokers and nonsmokers. Therefore,
this study was conducted to investigate the changes in
the hematological and hepatic functions only amongnonsmoking subjects following their benzene exposure
from the prolonged BP’s flaring incident [25]. The clinical
outcomes from benzene exposed nonsmoking subjects
were compared with those of unexposed nonsmoking
subjects.
The findings of the present study indicate that benzene
exposure can induce significant alterations in hematological
and hepatic functions among nonsmoking subjects.
Specifically, mean WBC and platelet counts were sig-
nificantly increased in benzene exposed subjects com-
pared with those unexposed subjects. Hemoglobin and
hematocrit levels were also elevated in benzene ex-
posed subjects compared with the unexposed subjects.
Similarly, the BUN and creatinine levels were signifi-
cantly increased in benzene exposed subjects com-
pared with the unexposed subjects. Although, several
previous studies reported similar findings [28-30], their
study population included both smoking and non-
smoking subjects.
Previously, it has been shown that benzene and other
chemicals present in petroleum refining affecst the liver
function [27]. Therefore, we assessed liver function by
examining the serum levels of ALP, AST and ALT among
benzene exposed subjects and compared them with the
unexposed subjects. The results demonstrated that the
Table 4 Comparison of hematological and hepatic indices by age group between unexposed and exposed nonsmoking
subjects to benzene
Variable Age Group Unexposedδ Exposedβ P value
WBC (× 103 per μL) < 40 years 7.3 ± 1.7 8.1 ± 2.8 0.001*
≥ 40 years 6.6 ± 1.6 7.6 ± 1.8 0.001*
Platelets (× 103 per μL) < 40 years 254.5 ± 55.3 286.9 ± 69.3 0.001*
≥ 40 years 239.6 ± 53.1 272.1 ± 71.1 0.001*
Hemoglobin (g per dL) < 40 years 13.9 ± 1.3 14.1 ± 1.8 0.13ψ
≥ 40 years 14.0 ± 1.2 13.9 ± 1.7 0.13ψ
Hematocrit (%) < 40 years 41.6 ± 3.6 41.8 ± 4.4 0.10ψ
≥ 40 years 42.0 ± 3.3 41.7 ± 4.4 0.13ψ
BUN (mg per dL) < 40 years 12.2 ± 3.1 12.6 ± 5.3 0.27ψ
≥ 40 years 14.8 ± 3.8 15.0 ± 5.7 0.25ψ
Creatinine (mg per dL) < 40 years 0.8 ± 0.2 1.0 ± 0.4 0.001*
≥ 40 years 0.8 ± 0.2 1.1 ± 0.3 0.001*
ALP (IU per L) < 40 years 70.2 ± 7.8 84.5 ± 11.3 0.001*
≥ 40 years 72.6 ± 8.6 89.4 ± 12.2 0.001*
AST (IU per L) < 40 years 19.1 ± 5.2 24.3 ± 5.7 0.001*
≥ 40 years 19.8 ± 5.3 26.1 ± 7.2 0.001*
ALT (IU per L) < 40 years 19.8 ± 6.2 30.7 ± 6.2 0.001*
≥ 40 years 20.6 ± 6.7 32.1 ± 7.1 0.001*
*Differences between benzene exposed and unexposed groups are significant.
ψ = did not reach statistical significance.
WBC White blood cells, BUN Blood urea nitrogen, ALP Alkaline phosphatase, AST Aspartate amino transferase, ALT Alanine amino transferase.
δUnexposed < 40 years: n = 128; δUnexposed ≥40 years: n = 201.
βExposed <40 years: n = 561; βExposed ≥40 years: n = 532.
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vated in the benzene exposed subjects compared with
those unexposed subjects. Several other investigators also
reported elevated liver enzymes among subjects exposed
to benzene or petroleum products and organic solvents
[31-35]. The increased serum levels of these enzymes
could be due to the overproduction or release of enzymes
from the liver cells in response to stimuli of hepatocellular
injury or cell death. However, the exact mechanisms for
overproduction or release of these serum enzymes in
benzene exposed subjects still remain to be elucidated.
In order to understand the effect of the benzene exposure
by gender and age we compared the outcomes by gender
as well as by age groups (<40 years and ≥ 40 years). Find-
ings of the study reveal that both the hematological and
hepatic functions were significantly affected in the benzene
exposure nonsmoking group compared with the unexposed
nonsmoking group irrespective of their gender or age.
We acknowledge that this study inevitably has several
limitations. A cross-sectional study design allows only
hypothesis-generating, and not causality to be investigated.
Thus, it is difficult to infer a causality using such a study
design because the clinical outcomes were measured at
one time point after exposure to benzene. Another short-
coming of this investigation was the retrospective natureof the study. Hence, further verification of the study find-
ings is required through additional prospective random-
ized studies. However, planning such randomized studies
to evaluate the health effects of benzene and other toxic
chemical release from a disaster may not be practical.
Nonetheless, the findings of this study reveal that expos-
ure to benzene is associated with significant adverse health
effects among nonsmoking subjects. These effects may
lead to the impairment in the function of hematological,
hepatic, renal and other organ functions. In addition, there
is significant scientific evidence that links benzene ex-
posure with an increased risk of carcinogenesis. It is,
therefore, important that those who are exposed to ben-
zene be closely followed over time to detect further
long-term toxicities to the bone marrow, liver, kidney
and other organs affected by the benzene exposure as
well as be monitored for the development of secondary
malignancies. To achieve this, health care providers
need to monitor those benzene exposed individuals with
frequent periodic checkups and laboratory blood work.
In addition, pulmonary, cardiac, neurologic and other
organ functions should be evaluated periodically to
monitor the long-term effects of benzene exposure.
Furthermore, to fully understand the importance and
nature of these effects, longitudinal and mechanistic studies
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As the health impact from benzene exposure is long-
lasting, close follow-up studies are necessary to determine
its long-term health effects in those affected populations.Conclusion
The findings of this study revealed that benzene exposure
has a potential to induce both hematological and hepatic
alterations among nonsmoking subjects. The hematological
alterations include increased WBC counts, platelet counts,
and creatinine in benzene exposed subjects compared with
unexposed subjects. Increased levels of ALP, AST, and ALT
in the serum indicate hepatic injury in subjects exposed to
benzene. It is emphasized, however, that this study was not
a controlled trial. The observed findings could be influ-
enced by compounding factors that are inherent to the
study design and since the procedures used did not follow a
predefined scheme, this may have biased the interpretation
of the results. Nonetheless, this study has shed light on
both the potential short-term and long-term health conse-
quences of benzene exposure among nonsmoking subjects.
Additional studies are being conducted to assess the poten-
tial health effects in those residents exposed to benzene that
resulted from the prolonged flaring incident at the BP re-
finery facility in Texas City, Texas.
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